These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 34656326)
1. Intrinsic disorder and phase transitions: Pieces in the puzzling role of the prion protein in health and disease. do Amaral MJ; Cordeiro Y Prog Mol Biol Transl Sci; 2021; 183():1-43. PubMed ID: 34656326 [TBL] [Abstract][Full Text] [Related]
2. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain. Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212 [TBL] [Abstract][Full Text] [Related]
3. Transition of the prion protein from a structured cellular form (PrP Baral PK; Yin J; Aguzzi A; James MNG Protein Sci; 2019 Dec; 28(12):2055-2063. PubMed ID: 31583788 [TBL] [Abstract][Full Text] [Related]
4. PrP P102L and Nearby Lysine Mutations Promote Spontaneous Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493 [TBL] [Abstract][Full Text] [Related]
5. Methionine oxidation within the prion protein. Bettinger J; Ghaemmaghami S Prion; 2020 Dec; 14(1):193-205. PubMed ID: 32744136 [TBL] [Abstract][Full Text] [Related]
6. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer. Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616 [TBL] [Abstract][Full Text] [Related]
7. Phase separation of the mammalian prion protein: Physiological and pathological perspectives. do Amaral MJ; Freire MHO; Almeida MS; Pinheiro AS; Cordeiro Y J Neurochem; 2023 Jul; 166(1):58-75. PubMed ID: 35149997 [TBL] [Abstract][Full Text] [Related]
8. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein. Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139 [TBL] [Abstract][Full Text] [Related]
9. Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells. Hara H; Chida J; Uchiyama K; Pasiana AD; Takahashi E; Kido H; Sakaguchi S Sci Rep; 2021 May; 11(1):10109. PubMed ID: 33980968 [TBL] [Abstract][Full Text] [Related]
10. Novel strain properties distinguishing sporadic prion diseases sharing prion protein genotype and prion type. Cracco L; Notari S; Cali I; Sy MS; Chen SG; Cohen ML; Ghetti B; Appleby BS; Zou WQ; Caughey B; Safar JG; Gambetti P Sci Rep; 2017 Jan; 7():38280. PubMed ID: 28091514 [TBL] [Abstract][Full Text] [Related]
11. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306 [TBL] [Abstract][Full Text] [Related]
12. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion. Hara H; Sakaguchi S Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321 [TBL] [Abstract][Full Text] [Related]
13. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106. Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549 [TBL] [Abstract][Full Text] [Related]
14. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions. Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946 [TBL] [Abstract][Full Text] [Related]
16. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts. Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701 [TBL] [Abstract][Full Text] [Related]
17. Cofactors influence the biological properties of infectious recombinant prions. Fernández-Borges N; Di Bari MA; Eraña H; Sánchez-Martín M; Pirisinu L; Parra B; Elezgarai SR; Vanni I; López-Moreno R; Vaccari G; Venegas V; Charco JM; Gil D; Harrathi C; D'Agostino C; Agrimi U; Mayoral T; Requena JR; Nonno R; Castilla J Acta Neuropathol; 2018 Feb; 135(2):179-199. PubMed ID: 29094186 [TBL] [Abstract][Full Text] [Related]
18. Anti-prion Protein Antibody 6D11 Restores Cellular Proteostasis of Prion Protein Through Disrupting Recycling Propagation of PrP Pankiewicz JE; Sanchez S; Kirshenbaum K; Kascsak RB; Kascsak RJ; Sadowski MJ Mol Neurobiol; 2019 Mar; 56(3):2073-2091. PubMed ID: 29987703 [TBL] [Abstract][Full Text] [Related]
19. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice. Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815 [TBL] [Abstract][Full Text] [Related]
20. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases. Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]